Recent Cancer Institute NSW grant outcomes
2009 (funding commencing 1 July 2009)
Cooperative Clinical Trials Infrastructure Grants
Simes J
Development and operational support for AGITG and ANZGOG through the NHMRC Clinical Trials Centre: A NSW-led initiative.
$1,745,788
Stockler M
Development and operational support for ALTG, ANZUP and COGNO through the NHMRC Clinical Trials Centre: A NSW-led initiative.
$925,917
Gebski V
Biostatistics, quality assurance and data systems for Cancer Trial Groups activities based at the NHMRC Clinical Trials Centre
$1,757,469
McCowage G
New mechanisms to facilitate collaborative efforts for paediatric cancer clinical trials.
$697,387
Research Equipment Grants
Fazekas de St Groth B
Next generation high speed cell sorter for cytometry and imaging facility
$760,000
Robinson P
A superior mass spectrometry system for ultra-sensitive cancer phosphoproteomics PALM Microbeam Laser Microdissection (LM)
$979,371
Richardson D
PALM Microbeam Laser Microdissection (LM) Microscope for the Multi-User Sydney Cancer Gene Expression Facility
$632,578
Research Infrastructure Grants
Reddel R
CellBank Australia
$660,000
Clarke C
Breast Cancer Tissue Bank - data collection and management infrastructure.
$450,000
Vadas M
Manager Imaging and Cytometry and Imaging Specialist for expanded Centenary Institute flow and imaging facility
$330,000
Butow P
The Psycho-oncology Co-operative Research Group: infrastructure to support operational activity and facility management to further psychosocial research and quality of life studies in clinical trials.
$330,000
Research Scholar Awards
Bach T
Understanding Focal Adhesion Dynamics in Cell Migration
$50,000
Stern J
Recruitment of human telomerase to telomeres
$37,500
Grzelak C
Role of the hepatic Hedgehog pathway in injury and hepatocellular carcinoma
$62,500
Yamagishi T
Development of Novel Chemotherapeutics for the Treatment of Leukaemia that Overcome Drug Resistance
$37,500
Dear R
The use of clinical trial registries to develop and evaluate a web site that informs patients about cancer clinical trials and facilitates their decision making
$32,500
Mohana Kumaran N
Apoptosis pathways in the drug resistance and pathogenesis of melanoma
$62,500
O’Connell M
Towards designer RNA-binding proteins (RBPs) as novel cancer biology probes and therapeutic agents
$62,500
Kiely B
Estimating Survival Duration and Communication of Prognostic Uncertainty in Patients with Incurable Cancer
$57,000
NSW Registrar Advanced Trainee Program
Lee S
Analysis for differentially expressed proteins in radiation sensitive and resistant rectal cancer cells.
2008 (funding commencing 1 January 2009)
Future Research Leader Grants
Mrass P
Direct visualization of T cell-tumour stroma cell interactions to dissect the molecular mechanisms of immune system-mediated tumour destruction
$1,167,710
Qiao L
Identification and characterization of liver cancer stem cells and their regulation by Notch signalling
$1,206,507
Research Equipment Grants
Robinson P
A Mass Spectrometer for NSW Cancer Phosphoproteomics Research
$300,000
Mann G
High-throughput virtual microscopy and data warehouse system
$293,886
Weninger W
Multi-photon microscope for intravital imaging
$300,000
Early Career Development Fellowships
Howell V
Ovarian cancer: Experimental models for understanding the molecular events important to this malignancy
$598,790 over 3 years
Kalinowski DS
Development of Novel Anti-Cancer Drugs with Marked and Selective Activity that Overcome Resistance to Established Chemotherapy
$588,598 over 3 years
Rahmanto SR
Novel insights into the role of melanoma tumour antigen p97
(melanotransferrin) in melanoma progression and pathogenesis
$593,197 over 3 years
Clinical Research Fellowship
Balleine R
Molecular grade as prognostic indicator in evasive breast cancer
$577,151 over 3 years
Sidhu S
Molecular Markers of Diagnosis, Outcome and Therapeutic Response in Malignant Adrenal Tumours
$564,126 over 3 years
Clinical Trial Grants (existing units)
Solomon M
Cancer Surgery Trials Unit
$169,232
Hamilton A
Sydney Cancer Centre, Royal Prince Alfred Hospital
$170,700
International Clinical and Research Fellowship
Lee MJ
Lower limb lymphoedema secondary to cancer treatment
$158,961 over 2 years
NSW Cancer Trials Network Cancer Trials Nurse and Data Manager Grants (Cancer Council NSW supported)
Thompson J
Sydney Melanoma Unit
$64,000
Research Innovation Grants
Reilly D
Imaging cancer using hyperpolarized nanodiamond
$50,000
Codd R
Biocombinatorial Synthesis of Histone Deacetylase Inhibitors as Chemotherapeutic Agents for Leukaemia and Lymphoma
$50,000
Kalinowski DS
Molecular Examination of the Role of Iron in Oestrogen-Dependent and - Independent Growth of Breast Cancer Cells
$50,000
Haass N
Intravital cell-cycle imaging as a novel approach to design combined targeting strategies of independent signalling pathways in melanoma
$49,284
Tattersall M
Exploring the influence of age-related factors in treatment decisions in advanced cancer
$50,000
Lyons J
Polyclonality in cancer
$48,500
Catchpoole D
Applications of systems biology for personalized medicine of childhood leukaemia
$48,380
King M
Development of cancer specific multi-attribute health states from the QLQC30 for use in economic evaluation
$47,814
Damian D
Immune effects of topical photodynamic therapy in humans
$50,000
Beith J
Feasibility of use of acupuncture for treatment of arthralgia secondary to aromatase inhibitor therapy in women with early breast cancer
$46,126
Research Scholars Award
Sharbeen G
Selective killing of mismatch repair deficient cancer cells
$25,000 over 1 year
Blinman P
Determining patients and doctors preferences for chemotherapy and incorporating them into clinical decision making
$35,000 over 2 years
Payne C
Oligodendrogliomas with LOH 1p19q: Identifying Genes associated with Therapeutic Chemosensitivity
$50,000 over 2 years
Fardell J
Chemotherapy and cognitive decline: Is exercise a remedy?
$50,000 over 2 years
Tacon LJ
Molecular mechanisms of adrenocortical tumorigenesis and response to therapy
$50,000 over 2 years
Walker S
The role of adiponectin in hepatocellular carcinoma
$75,000 over 3 years